Background: Regarding risk of bacterial meningitis (BM) after Cochlear implantation (CI), it was suggested to receive polyvalent conjugate vaccine. We aimed to estimate the prevalence of BM post CI in child recipients who do not receive polyvalent vaccine.
INTRODUCTION
The utilization of cochlear implant in children began from 1980. [1] These instruments conduct electrical stimulation through their electrodes to a bundle of the cochlear nerve fibers and provide effective and safe method of rehabilitation for patients with severe to profound hearing loss. [2, 3] Early and late complications may follow this complex surgical dilemma. [3] Apart from device, technique and human related complications, there is a higher risk of otogenic meningitis after this procedure. Children with a cochlear implant may have a greater risk of developing bacterial meningitis (BM) compared with the general population.
Cochlear implantation (CI) candidates, as well as those individuals who have already received the implant, may benefit from immunizations against organisms that commonly cause BM, particularly streptococcus pneumonia. [5] [6] All candidates for and recipients of cochlear implants should be up-to-date with their immunizations. However, polyvalent pneumococcal conjugate vaccine is not administered in routine vaccination schedule in our country. In this study, our aim was to detect the incidence of BM in cochlear implant recipients who do not receive routine polyvalent pneumococcal conjugate vaccine in their immunization program.
METHODS
In this prospective study, we studied 371 children with history of CI due to profound sensorineural hearing loss between 2007 and 2010. These children were followed-up after surgery to detect signs of developing BM.
None of the children received polyvalent pneumococcal conjugates vaccine before or after surgery, with regard to the fact that this vaccine is not utilized as a part of routine immunization program in our country. Moreover, the prophylactic antibiotic therapy before and after implantation did not performed in any cases.
The diagnostic criteria for BM were based on clinical and laboratory basis: [1] Clinical findings in favor of meningitis such as headache, fever, drowsiness, neck stiffness, etc. [2] Abnormal cerebrospinal fluid (CSF) analysis such as turbid appearance, increased protein, decreased glucose and increased leukocytes and [3] the most important part was based on isolation of bacteria from blood or CSF. If the diagnosis of the BM was confirmed according to the above criteria, the patients were treated with a wide spectrum antibiotics based on antibiogram susceptibility test and trends of clinical symptoms and signs. A sub-specialist in pediatric infectious diseases was handled these patients.
RESULTS
From 371 patients with a cochlear implant, 1 patient (0.3%) experienced BM after surgery. The age of this female patient was 24 months, and mean age of patients without postsurgical meningitis was 36.7 ± 23.2 months. Parents of an infected child had consanguineous marriage and educated up to secondary school. The infected child had a complete immunization history; and further interview with parents revealed that the child had a history of severe upper respiratory tract infection that caused her to be hospitalized during her first month of life. According to Table 1 , the education level of parents was reported to be at "college level or higher" Less than one half of noninfected patients, while about 65% of patients were a product of consanguineous marriage. Almost all of the children showed a complete history of vaccination. The demographic data of the non-infected group is reflected in Table 1 .
DISCUSSION
Complications such as mastoiditis and otogenic meningitis can also develop from a middle ear infection and are still potentially life-threatening. Unfortunately, in recent years more cases of meningitis after CI, even fatal, has been reported. On the other hand, there are numerous studies, which claim that the trauma caused by this surgical procedure can increase the risk of postsurgical bacterial infection. [4, 7, [8] [9] [10] [11] [12] [13] However, the extent of injury, which leads to postsurgical meningitis has not yet been proven. There are some clinical studies, which have estimated the risk of meningitis after implantation. [4] Some types of cochlear prostheses have been accompanied with a higher rate of meningitis possibly due to electrode array position, which is consisted of two components. [14] Today in developed countries, immunization against BM is a part of routine vaccination program and it is also recommended in children who undergo surgical procedures, which increase the risk of post operation meningitis. By means of wide immunization program, the incidence of meningitis has dramatically decreased. Results from the outcome of inducing immunization program in European and North American countries demonstrate the dramatic decrease in the incidence of BM among infants. [15, 16] In contrast, providing polyvalent meningitis vaccine for children and patients prone to BM is still a subject of challenge for developing countries, due to their financial burden.
There are numerous studies, which have proven the effect of socioeconomic factors, such as parental level of education on the incidence of meningitis in children. Low income, crowded families, and low educational levels of parents as well as some environmental factors (such as parental smoking habits) enhance the rate of meningitis in children. [17, 18] we also could detect that there was a trend for the higher number of infected children in families with lower level of education.
There are some similar studies, which conducted on the prevalence of BM in cochlear implanted children and they assessed the efficacy of vaccination in preventing this complication. In our study, the patients have not previously received vaccination although many studies confirmed the role of vaccination in preventing the meningitis.
We just found one case of BM among 371 implanted children and the rate of BM in our study was 0.3%. Based on US Food and Drug Administration's public health notification, "118 of the 60,000 people who received cochlear implants over the past 20 years have acquired meningitis." [5] It means that in 2008, the worldwide rate of post implantation meningitis is equal to 0.002%, which is so less than our result. Moreover, they suggested that "pneumococcal meningitis is more likely in patients who receive CI, and that the surgical insertion technique and the cochlear implant design should be nontraumatic, and that all cochlear implant recipients should be offered vaccination against Streptococcus pneumoniae."
Nowadays, in developed countries, polyvalent vaccine is used in patients' candidate for CI. The rate of meningitis in our study was 150 times more than the rate of post implantation meningitis in developed countries, but the overall prevalence of BM in our country, [19] Iran (about 10 cases/100,000 population), is so higher than the prevalence in developed countries (1.38 cases/100,000 population). [20] When this data was compared, it was cleared that the post implantation meningitis in our country was higher than in developed country as well as the higher prevalence of meningitis in Iranian general population compared to developed communities.
In a study in United Stated described that the incidence of pneumococcal meningitis in cochlear implanted children is 30 times higher than that for children in the general US population." [11] While based on this study and other studies this ratio in Iran is 33 times. Therefore, the prevalence of post implantation meningitis compared to the general population in Iran and developed countries is almost similar. Also, in a review study by Wei et al. demonstrated that "Based on the current clinical literature, it is difficult to determine whether CI per se increases the risk of meningitis in subjects with no existing risk factors for acquiring the disease." [21] Moreover, vaccination provide more effective protection against hematogenous bacterial source of meningitis, while it cannot be effective on the inner ear bacterial source of meningitis that is the important source of post implantation meningitis. [4] On the other hand, cochlear device could be usefully implanted among post meningitis deaf children and also implantation works well after postsurgery meningitis also temporary loss of implant usage was reported. [22, 23] 
CONCLUSIONS
We believe that the risk of meningitis after CI in children without pneumococcal immunization in our study was even lower than many other studies who utilized immunization against pneumococcal meningitis before and after surgery. [24] However, this conclusion may be due to the small number of patients enrolled in the study, we are not able to give a strong suggestion about the matter. We can also conclude that CI could safely be performed in countries that do not make use of pneumococcal vaccine in their routine schedule due to their consideration.
